T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy.

Arizcorreta, A

T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy. [electronic resource] - Clinical and experimental immunology Nov 2006 - 270-7 p. digital

Publication Type: Journal Article

0009-9104

10.1111/j.1365-2249.2006.03220.x doi


Adult
Antiretroviral Therapy, Highly Active
Antiviral Agents--therapeutic use
CD4-Positive T-Lymphocytes--drug effects
CD8-Positive T-Lymphocytes--drug effects
Female
Follow-Up Studies
Gene Rearrangement, T-Lymphocyte
HIV Infections--complications
Hepatitis C, Chronic--complications
Humans
Interferon alpha-2
Interferon-alpha--therapeutic use
Leukocyte Common Antigens--blood
Male
Polyethylene Glycols--therapeutic use
Prospective Studies
Receptors, Antigen, T-Cell--genetics
Recombinant Proteins
Ribavirin--therapeutic use
T-Lymphocyte Subsets--drug effects
Thymus Gland--immunology
Treatment Outcome